| Value | ₹354.5 Cr |
|---|
BSE filing, BSE: 544657. Summary written from the filing by ALFA Finder's alert engine.
Pajson Agro India Ltd: key numbers
- Share price
- ₹298.90
- Market cap
- ₹711.7 Cr
- Revenue (annual)
- ₹255.7 Cr
- Net profit (annual)
- ₹24.78 Cr
- P/E (TTM)
- 28.7×Sector 45.0×
- Promoter holding
- 62.47%
- FII holding
- 0.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pajson Agro India Ltd
All →Pajson Agro India Acquisition Worth ₹354.5 Cr
Pajson Agro's board approved acquiring 100% of Pacific Global FZCO for Rs 354.52 Crore via share swap. A preferential issue and EGM on December 4 follow.
- Value
- ₹354.5 Cr
Pajson Agro India Results Update
Pajson Agro India Limited reported H1 FY27 total income of ₹145.11 crore with 23% YoY growth. The company is tripling capacity with a 35,000 MTPA greenfield facility.
- processing capacity
- 35000.0 MTPA
Pajson Agro India Other Announcement
Pajson Agro India confirmed no deviation in its IPO proceeds use for the half year to September 2026. This is a routine Regulation 32 compliance filing.
Pajson Agro India H1 FY27 Results: Net Profit ₹12.6 Cr, Down 11.3% YoY
Pajson Agro India Ltd reported revenue from operations of ₹143.4 Cr (+21.1% YoY) and net profit of ₹12.6 Cr (-11.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹12.6 Cr · -11.3% YoY
Pajson Agro India Board Meeting Date
Pajson Agro India Ltd intimated a Board meeting on 02 Nov 2026 to consider unaudited H1 FY27 results. No financial figures are disclosed in this advance notice.
Pajson Agro India Other Announcement
Pajson Agro India Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Other fund raise announcements
All →Evonile Pharma Fund Raise of ₹900 Cr
Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.
- Value
- ₹900.0 Cr
Lloyds Metals & Energy Fund Raise
Lloyds Metals and Energy's board approved a fund raise, with the mode of financing yet to be decided. Investors should watch for the eventual issuance structure and size.
Shlokka Dyes Fund Raise of ₹24.5 Cr
Shlokka Dyes board approved a ₹24.50 Crore preferential issue of equity shares and warrants. Shareholder approval is pending at a November 28, 2026 meeting.
- Value
- ₹24.50 Cr
Crescentis Capital Fund Raise of ₹79.62 Cr
Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.
- Value
- ₹79.62 Cr
- Execution
- Issue opening November 16, 2026; closing November 27, 2026; listing on or about December 3, 2026
Acetech E-Commerce Fund Raise of ₹40 Cr
Acetech E-Commerce approved a ₹40 Crore Rights Issue and 70% acquisition of Unique Cookware (₹10.41 Crore). Both decisions will fund expansion into cookware and allied products.
- Value
- ₹40.00 Cr
Shree Pushkar Chemicals & Fertilisers Fund Raise of ₹45 Cr
Shree Pushkar's board approved a preferential issue of 854,060 convertible warrants to Punit Makharia. The issue would raise about Rs.45.00 Crore at Rs.527 per warrant.
- Value
- ₹45.00 Cr